Nektar Therapeutics Balance Sheet (2010-2026) | NKTR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	152.34M	54.02M	25.22M	67.99M	77.55M	105.76M	88.23M	76.95M	50.73M	64.92M	35.28M	48.64M	27.94M	30.11M	44.25M	38.89M	42.99M	41.03M	15.12M	149.58M
Short-term Investments (Quarter)	847.72M	867.06M	708.74M	599.03M	541.77M	440.63M	416.75M	379.87M	358.70M	307.74M	268.34M	240.60M	243.29M	214.39M	210.97M	179.74M	132.91M	229.18M	230.64M	419.03M
Cash & Current Investments (Quarter)	1,000.07M	921.08M	733.96M	667.02M	619.32M	546.39M	504.98M	456.83M	409.43M	372.66M	303.62M	289.24M	271.24M	244.50M	255.23M	218.63M	175.90M	270.21M	245.75M	568.60M
Receivables - Net (Quarter)	28.87M	28.99M	22.49M	30.22M	10.01M	11.53M	5.98M	3.00M	1.33M	2.20M	1.21M	3.62M	1.20M					0.20M	0.40M
Receivables - Other (Quarter)			1.40M				0.70M				0.50M				1.10M				0.60M
Receivables (Quarter)	28.87M	28.99M	23.89M	30.22M	10.01M	11.53M	6.68M	3.00M	1.33M	2.20M	1.71M	3.62M	1.20M		1.10M			0.20M	1.00M
Raw Materials (Quarter)							2.58M			1.92M	1.86M	1.94M	1.72M
Work In Process (Quarter)							10.75M			12.29M	12.88M	9.96M	10.59M
Finished Goods (Quarter)							5.88M			0.92M	1.36M	4.34M	2.16M
Inventory (Quarter)	14.62M	15.33M	15.80M	15.38M	16.97M	19.06M	19.20M	20.23M	20.69M	15.13M	16.10M	16.24M	14.46M
Prepaid Assets (Quarter)	12.60M	20.73M	23.33M	20.83M	19.25M	22.51M	15.81M	11.01M	9.60M	9.03M	9.78M	10.74M	8.29M	8.93M	6.07M	11.28M	10.66M	11.15M	20.51M	20.44M
Current Assets (Quarter)	1,056.15M	986.13M	795.58M	733.46M	665.54M	599.48M	545.97M	491.07M	441.06M	399.02M	330.70M	319.84M	295.19M	286.48M	261.29M	229.91M	186.57M	281.36M	266.27M	589.04M
Non-Current Assets
Construction in Progress (Quarter)			7.16M				2.53M	0.81M	0.46M	0.49M	0.74M		0.72M	0.14M	0.24M
Property, Plant & Equipment (Net) (Quarter)	58.60M	58.83M	60.51M	60.98M	39.79M	36.80M	32.45M	27.08M	22.55M	19.95M	18.86M	17.48M	15.19M	3.60M	3.41M	3.16M	2.99M	2.83M	2.06M
Long-Term Investments (Quarter)	57.40M	34.22M	64.83M	37.36M	8.93M						25.82M	36.78M	19.41M	4.54M	12.22M	7.76M	5.37M			162.99M
Goodwill (Quarter)	76.50M	76.50M	76.50M	76.50M	76.50M	76.50M	76.50M
Goodwill & Intangibles (Quarter)	76.50M	76.50M	76.50M	76.50M	76.50M	76.50M	76.50M
Other Non-Current Assets (Quarter)	0.34M	1.84M	2.74M	1.52M	2.23M	2.32M	2.25M	1.41M	1.65M	4.52M	4.64M	4.66M	4.31M	4.52M	4.65M	5.39M	5.02M	5.16M	14.14M	11.24M
Non-Current Assets (Quarter)	315.20M	291.11M	321.61M	290.66M	196.45M	181.52M	164.63M	70.68M	53.22M	43.22M	67.33M	76.18M	48.15M	21.48M	42.56M	26.33M	20.97M	19.99M	14.14M	174.23M
Assets (Quarter)	1,371.35M	1,277.24M	1,117.19M	1,024.12M	861.99M	781.01M	710.60M	561.74M	494.28M	442.24M	398.03M	396.01M	343.33M	307.97M	303.85M	256.24M	207.53M	301.35M	280.41M	763.27M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	19.70M	23.66M	9.75M	12.62M	12.35M	5.33M	12.98M	3.70M	2.62M	3.29M	9.85M	8.76M	6.47M	8.58M	11.56M	17.83M	14.28M	15.56M	10.77M	10.03M
Payables (Quarter)	19.70M	23.66M	9.75M	12.62M	12.35M	5.33M	12.98M	3.70M	2.62M	3.29M	9.85M	8.76M	6.47M	8.58M	11.56M	17.83M	14.28M	15.56M	10.77M	10.03M
Accumulated Expenses (Quarter)	28.66M	32.88M	15.73M	22.65M	30.32M	24.39M	9.58M	37.41M	29.14M	11.48M	5.55M	7.38M	29.51M	7.01M	29.97M	5.03M	35.10M	8.61M	2.94M	5.01M
Other Accumulated Expenses (Quarter)	16.40M	19.97M	15.47M	17.01M	13.04M	15.30M	7.00M			6.95M	3.47M	8.31M	11.06M	17.92M	9.92M	11.82M	15.45M	12.08M	2.72M	4.06M
Short term Debt (Quarter)
Current Leases (Quarter)	16.78M	17.74M	17.44M	19.60M	20.05M	18.51M	18.67M	18.77M	18.93M	19.09M	19.26M	19.37M	21.34M	21.50M	19.87M	21.84M	22.01M	22.18M	20.50M	22.53M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	131.02M	139.97M	85.20M	105.28M	104.98M	83.99M	68.20M	59.88M	50.69M	52.11M	51.27M	52.41M	57.33M	67.58M	61.40M	70.93M	71.39M	66.34M	53.54M	57.71M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Liabilities from Discontinued Operations (Quarter)														5.12M
Operating Leases (Quarter)	131.66M	128.72M	125.74M	122.64M	119.42M	116.14M	112.83M	109.39M	105.82M	102.19M	98.52M	94.71M	90.76M	86.76M	82.70M	78.50M	74.14M	69.73M	65.26M	60.63M
Other Non-Current Liabilities (Quarter)	11.61M	21.39M	3.59M		2.08M	3.05M	7.55M	6.48M	5.15M	4.96M	4.63M	4.33M	8.05M	6.91M	7.24M	6.76M	5.64M	5.03M	8.62M	8.45M
Total Non-Current Liabilities (Quarter)	454.77M	454.32M	434.09M	416.23M	401.18M	365.73M	336.41M	314.40M	292.17M	277.92M	262.41M	264.97M	255.59M	252.17M	235.87M	235.75M	226.11M	211.24M	181.95M	178.61M
Total Liabilities (Quarter)	466.38M	475.70M	437.68M	416.23M	403.25M	368.78M	343.96M	320.88M	297.32M	282.88M	267.05M	269.31M	263.65M	259.08M	243.11M	242.50M	231.75M	216.26M	190.57M	187.06M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	904.98M	801.54M	679.51M	607.89M	458.73M	412.22M	366.64M	240.87M	196.96M	159.37M	130.99M	126.70M	79.69M	48.88M	60.74M	13.74M	-24.21M	85.09M	89.83M	576.22M
Shareholder's Equity (Quarter)	904.98M	801.54M	679.51M	607.89M	458.73M	412.22M	366.64M	240.87M	196.96M	159.37M	130.99M	126.70M	79.69M	48.88M	60.74M	13.74M	-24.21M	85.09M	89.83M	576.22M
Liabilities and Shareholders Equity (Quarter)	1,371.35M	1,277.24M	1,117.19M	1,024.12M	861.99M	781.01M	710.60M	561.74M	494.28M	442.24M	398.03M	396.01M	343.33M	307.97M	303.85M	256.24M	207.53M	301.35M	280.41M	763.27M
Treasury Shares (Quarter)			9.93M				9.31M				4.23M	0.55M	0.55M	0.55M	0.55M	0.55M	0.55M
Retained Earnings (Quarter)	-2557.64M	-2687.35M	-4.16M	-2923.39M	-8.19M	-3141.51M	-3201.19M	-3338.21M	-3389.33M	-6.35M	-3477.25M	-0.40M	-0.49M	0.35M	0.06M	-3647.09M	-3688.68M	-3724.21M	0.02M	-3805.19M

Research Tools

Developers

Nektar Therapeutics Balance Sheet (2010-2026) | NKTR

Research Tools

Developers

Nektar Therapeutics Balance Sheet (2010-2026) | NKTR

Create an account

Sign In

Reset Password